
TUFLIN™ HS-7023 NT 7 Linear Low Density Polyethylene Resin is an ethylene-hexene copolymer, linear low density (LLDPE) resin designed for good strength and processability. This resin is formulated with an additive package that does not contain any intentionally added TNPP (TrisnonylphenylPhosphite). This product is recommended for general purpose packaging applications from thick gauge, heavy duty bags to high speed thin gauge applications. Main Characteristics Hexene linear low density resin General purpose resin Excellent strength An additive present in this product limits use only in film form for food contact applications Complies with U.S. FDA 21 CFR 177.1520 (C) 3.1a (with Restrictions) U.S. FDA FCN 1539 (see notes) EU, No 10/2011 Consult the regulations for complete details. Additive Antiblock: No Processing Aid: No Slip: No Notes: An additive present in this product limits use only in film form for food contact applications. When used unmodified for food contact applications, this resin will comply with the U.S. Food and Drug Administration as a food contact substance (FCN) as a result of a premarket notification with an effective date of June 19, 2015 under FCN 1539. This notification allows for use of this product as articles or components of articles used in contact with all food types under Conditions of Use A through H, with the exception of infant formula or human breast milk, as described in Table 2 of U.S. FDA CFSAN/Office of Food Additive Safety April 2006, "Definitions of Food Types and Conditions of Use for Food Contact Substances". The preceding statement refers to regulatory requirements only, not to the product's physical utility. It is the responsibility of the article producer or food packager to determine that the article is suitable for its intended use.
Shape: Pellets · Density: 0.918 g/cm³ · Melting Point: 124 °C · MFI: 1 g/10 min
Any and all medical application use of Dow materials, whether a device, a component, or any type of primary or secondary packaging of a medically related object or substance, needs to be reviewed and approved by Dow before any Dow material can be tested in such Policy application. Dow requests that customers considering use of Dow products in medical applications notify Dow so that appropriate assessments may be conducted. Dow does not endorse or claim suitability of its products for specific medical applications. It is the responsibility of the medical device or pharmaceutical manufacturer to determine that the Dow product is safe, lawful, and technically suitable for the intended use. DOW MAKES NO WARRANTIES, EXPRESS OR IMPLIED, CONCERNING THE SUITABILITY OF ANY DOW PRODUCT FOR USE IN MEDICAL APPLICATIONS. For further information contact your Dow sales or technical representative to request a Medical Application Review Request Form. Additional details of Dow's Medical Applications Policy are available at: https://www.dow.com/en-us/support/product-safety.html Tobacco and Dow does not support or intend for its products to be used, directly or indirectly, in the production of tobacco, the manufacture of tobacco products, the manufacture and use of Marijuana Policy electronic cigarettes (including vaping devices), the production of marijuana, or the manufacture of marijuana products intended for human consumption, where the Dow product (or its residues) may be present in the finished product or be alleged to facilitate the delivery of nicotine, other tobacco components, marijuana, or marijuana components. Harmful